Vertex Pharmaceuticals Stock Jumps as Non-Opioid Painkiller Gets FDA Approval

Key TakeawaysVertex Pharmaceuticals' non-opioid painkiller received approval from the Food and Drug Administration.The drugmaker said the twice-daily pill, Journavx, is the first such treatment to hit the market in 20 years.Vertex set the U.S. wholesale price of Journavx at $15.50 per 50mg pill. Shares of Vertex Pharmaceuticals (VRTX) surged Friday, a day after the drugmaker reported federal regulators have approved its non-opioid painkiller, the first such drug to head to market in two decades. The company ...